B. Berman

发表

Newer technologies/techniques and tools in the diagnosis of melanoma.

Jitendrakumar K Patel, S. Konda, O. Perez, 2008, European journal of dermatology : EJD.

Ingenol mebutate gel for actinic keratosis.

Neil Swanson, Mark Lebwohl, M. Lebwohl, 2012, The New England journal of medicine.

Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation.

C. Cockerell, B. Berman, 2013, Journal of the American Academy of Dermatology.

Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis

B. Berman, 2015, Expert opinion on drug safety.

Prevention of Tuberculosis Infections in Patients Considered for Anti-TNF-α Therapy: Practical Application of National Psoriasis Foundation Consensus Statement

B. Berman, R. Huo, S. Sikaria, 2010 .

Updates on Keloidal Wound Healing

A. Maderal, B. Berman, 2016, Current Dermatology Reports.

Treatment of warts

B. Berman, A. Weinstein, 2000 .

Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids.

B. Berman, Joely Kaufman, 2002, Journal of the American Academy of Dermatology.

New Therapies for the Management of Keloids

B. Berman, V. Poochareon, Varee N. Poochareon, 2003, The Journal of craniofacial surgery.

Treatment of keloid scars post-shave excision with imiquimod 5% cream: A prospective, double-blind, placebo-controlled pilot study.

O. Perez, B. Berman, Catherine Harrison-Balestra, 2009, Journal of drugs in dermatology : JDD.

Two antigenically distinct species of human interferon.

J. Vilček, E. A. Havell, B. Berman, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Anti-IgE Therapy

A. Maderal, B. Berman, 2018 .

Mechanisms of action of new treatment modalities for actinic keratosis.

B. Berman, C. Ramirez, A. Villa, 2006, Journal of drugs in dermatology : JDD.

Efficacy and safety of ingenol mebutate 0.015% gel 3 weeks after cryosurgery of actinic keratosis: 11-week results.

N. Swanson, T. Skov, S. Tyring, 2014, Journal of drugs in dermatology : JDD.

Photobiomodulation with non-thermal lasers: Mechanisms of action and therapeutic uses in dermatology and aesthetic medicine

R. Kirsner, D. Goldberg, M. Gold, 2017, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Variables in Cryosurgery Technique Associated With Clearance of Actinic Keratosis

A. Shabbir, B. Berman, K. Knudsen, 2017, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Assessment of local skin reactions with a sequential regimen of cryosurgery followed by ingenol mebutate gel, 0.015%, in patients with actinic keratosis

G. Goldenberg, B. Berman, 2014, Clinical, cosmetic and investigational dermatology.

Nonsurgical innovations in the treatment of nonmelanoma skin cancer.

S. Amini, B. Berman, M. Viera, 2010, The Journal of clinical and aesthetic dermatology.

Innovative therapies in the treatment of keloids and hypertrophic scars.

S. Amini, B. Berman, M. Viera, 2010, The Journal of clinical and aesthetic dermatology.

Integrating Skin Cancer-Related Technologies into Clinical Practice.

D. Rigel, A. Sober, C. Cockerell, 2017, Dermatologic clinics.

Ultrasonic assessment of cutaneous atrophy caused by intradermal corticosteroids.

D. Miller, B. Berman, E. C. Gomez, 1982, The Journal of dermatologic surgery and oncology.

Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest

Y. Assaraf, B. Berman, D. Sheban, 2014, Cell Death and Disease.

Three-day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: A Phase II Trial.

S. Tyring, D. Siegel, B. Berman, 2017, The Journal of clinical and aesthetic dermatology.

Safety and Efficacy of Oral Polypodium leucotomos Extract in Healthy Adult Subjects.

B. Berman, M. Nestor, N. Swenson, 2015, The Journal of clinical and aesthetic dermatology.

Multicentric reticulohistiocytosis associated with recurrent breast carcinoma.

B. Berman, I. Valencia, A. Colsky, 1998, Journal of the American Academy of Dermatology.

Vaccines for Viral Diseases

B. Berman, I. Camacho, 2011 .

Efficacy of pentoxifylline in the treatment of pruritic papular eruption of HIV-infected persons.

B. Berman, G. Burke, F. Flores, 1998, Journal of the American Academy of Dermatology.

Tumor necrosis factor-α (TNF-α), interferon-α (IFN-α) and interferon-γ (IFN-γ) receptors on human normal and scleroderma dermal fibroblasts in vitro

B. Berman, J. Wietzerbin, 1992 .

Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta.

B. Berman, M. Duncan, B. Berman, 1989, The Journal of investigative dermatology.

Novel Opportunities in the Treatment and Prevention of Scarring

B. Berman, Adriana M Villa, C. Ramirez, 2004, Journal of cutaneous medicine and surgery.

Oncostatin M stimulates collagen and glycosaminoglycan production by cultured normal dermal fibroblasts: insensitivity of sclerodermal and keloidal fibroblasts.

B. Berman, M. Duncan, A. Hasan, 1995, The Journal of investigative dermatology.

Pentoxifylline, pentifylline, and interferons decrease type I and III procollagen mRNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation.

B. Berman, M. Duncan, A. Hasan, 1995, The Journal of investigative dermatology.

Pentoxifylline inhibits certain constitutive and tumor necrosis factor-alpha-induced activities of human normal dermal fibroblasts.

B. Berman, M. Duncan, J. Wietzerbin, 1992, The Journal of investigative dermatology.

Evaluation of interferon alpha2 (SCH 30500) in the treatment of condyloma acuminatum

K. Hatch, R. Reichman, B. Berman, 1988 .

Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment

M. Lebwohl, D. Rigel, L. Ferris, 2019, SKIN The Journal of Cutaneous Medicine.

Cellular binding characteristics of human interferon.

J. Vilček, B. Berman, 1974, Virology.

Immunomodulators for skin cancer.

B. Berman, Adriana M Villa, Adriana M. Villa, 2004, Journal of drugs in dermatology : JDD.

Cultured fibroblasts in avian scleroderma, an autoimmune fibrotic disease, display an activated phenotype.

T. Wilson, M. Gershwin, J. A. Van de Water, 1992, Journal of autoimmunity.

Human herpesviruses 6 and 7.

B. Berman, A. Weinstein, T. de Araujo, 2002, Dermatologic clinics.

What ’ s New in Natural Compounds for Photoprotection ?

S. Amini, B. Berman, R. Huo, 2022 .

Pharmacotherapy of actinic keratosis: an update

S. Amini, B. Berman, 2012, Expert opinion on pharmacotherapy.

Pharmacotherapy of actinic keratosis

S. Amini, B. Berman, W. Valins, 2009, Expert opinion on pharmacotherapy.

Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris.

K. Hatch, R. Reichman, B. Berman, 1986, Archives of dermatology.

Rethinking the Journal Impact Factor and Publishing in the Digital Age.

B. Berman, J. D. Del Rosso, M. Nestor, 2020, The Journal of clinical and aesthetic dermatology.

The effectiveness of a new method for assessing induration.

B. Berman, A. Burdick, A. Jonusas, 1998, Journal of the American Academy of Dermatology.

Expression of Fas‐receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle

M. Nadji, B. Berman, T. Sullivan, 2003, The British journal of dermatology.

Th17/Tc17 infiltration and associated cytokine gene expression in elicitation phase of allergic contact dermatitis

B. Berman, 2011 .

Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment

A. Maderal, B. Berman, Brian A. Raphael, 2017, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

A comparative study evaluating the tolerability and efficacy of two topical therapies for the treatment of keloids and hypertrophic scars.

S. Konda, O. Perez, S. Amini, 2010, Journal of drugs in dermatology : JDD.

Induction of HLA-DR by Interferon-γ Requires a Trypsin-Like Protease

B. Berman, G. Merlin, Bonnie Smith, 1991 .

Evaluation of Superficial Basal Cell Carcinomas After Treatment With Imiquimod 5% Cream or Vehicle for Apoptosis and Lymphocyte Phenotyping

B. Berman, V. Vincek, T. Sullivan, 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Role of Langerhans Cells in Cutaneous Immunological Reactions

B. Berman, R. Baer, 1981 .

Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alpha,-beta, and-gamma

B. Berman, M. Duncan, 2004, Archives of Dermatological Research.

Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells.

V. Ziboh, M. Palladino, B. Berman, 1985, The Journal of investigative dermatology.

Characterization of a glucocorticosteroid-induced inhibitor of interferon-gamma induction of HLA-DR expression.

B. Berman, B. Smith, 1992, The Journal of investigative dermatology.

Trypsin inihibitors inhibit induction by interferon-γ of HLA-DR antigen expression on human skin cells

B. Berman, Bonnie Smith, 1989 .

Pharmacotherapy of Basal Cell Carcinoma, Anogenital Warts, and Actinic Keratoses: Focus on Topical Imiquimod

S. Amini, B. Berman, C. Caperton, 2011 .

Successful treatment of extramammary Paget's disease of the scrotum with imiquimod 5% cream

G. Elgart, B. Berman, V. Poochareon, 2003, Clinical and experimental dermatology.

Imiquimod: a new immune response modifier for the treatment of external genital warts and other diseases in dermatology

B. Berman, 2002, International journal of dermatology.

Halo giant congenital melanocytic nevus: in vitro immunologic studies.

B. Berman, D. France, D. Altchek, 1988, Journal of the American Academy of Dermatology.

Epidermal Langerhans cell density in patients with pulmonary malignancies and chronic obstructive pulmonary disease.

P. Krumpe, B. Berman, B. Smith, 1987, The Journal of dermatologic surgery and oncology.

Reduced epidermal Langerhans cell densities in patients with pulmonary malignancies do not correlate with anergy or nutritional status.

J. Fox, B. Berman, R. Goodman, 1985, The Journal of dermatologic surgery and oncology.

Anatomical mapping of epidermal Langerhans cell densities in adults

B. Berman, D. France, G. Petroni, 1983, The British journal of dermatology.

T6-antigen-bearing cells in eosinophilic granuloma of bone.

J. Fox, B. Berman, 1983, JAMA.

Immune Response Modulators in the Treatment of Skin Cancer

S. Amini, B. Berman, M. Viera, 2011 .

Purification, Characterization, and Attempts at Isotopic Labeling of Mouse Interferon

B. Berman, K. Paucker, R. Golgher, 1970, Journal of virology.

Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity.

B. Berman, M. Duncan, B. Berman, 1989, The Journal of investigative dermatology.

Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons.

B. Berman, M. Duncan, 1987, The Journal of clinical investigation.

Topical application of imiquimod 5% cream to keloids alters expression genes associated with apoptosis

B. Berman, V. Vincek, M. Nassiri, 2003, The British journal of dermatology.

Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action

A. Grada, E. Stockfleth, B. Berman, 2022, Clinical, cosmetic and investigational dermatology.

CCID_A_374122 2495..2506

A. Grada, E. Stockfleth, B. Berman, 2022 .

Consensus Guidelines on the Use of Superficial Radiation Therapy for Treating Nonmelanoma Skin Cancers and Keloids.

A. Cognetta, C. Cockerell, M. Gold, 2019, The Journal of clinical and aesthetic dermatology.

Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6.

B. Berman, M. Duncan, M R Duncan, 1991, The Journal of investigative dermatology.

Comparison of a silicone gel-filled cushion and silicon gel sheeting for the treatment of hypertrophic or keloid scars.

B. Berman, F. Flores, 1999, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Effects of a water-impermeable, non-silicone-based occlusive dressing on keloids.

B. Berman, H. Bieley, 1996, Journal of the American Academy of Dermatology.

An open label safety study of topical imiquimod 5% cream in the treatment of Molluscum contagiosum in children.

S. Kapoor, B. Berman, A. Barba, 2001, Dermatology online journal.

Dermal sensitizing potential of glutaraldehyde: a review and recent observations

B. Ballantyne, B. Berman, 1984 .

Treatment of Keloids and Scars

A. Vivas, B. Berman, M. Viera, 2013 .

Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation

B. Berman, M. Duncan, M R Duncan, 1985, The Journal of experimental medicine.

Imiquimod 5% Cream for Keloid Management

B. Berman, Adriana M Villa, Adriana M. Villa, 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Polypodium Leucotomos--An Overview of Basic Investigative Findings.

C. Elmets, B. Berman, C. Ellis, 2016, Journal of drugs in dermatology : JDD.

Successful treatment of butcher's warts with imiquimod 5% cream

B. Berman, V. Poochareon, A. Villa, 2003, Clinical and experimental dermatology.

Decrease of ultraviolet A light-induced "common deletion" in healthy volunteers after oral Polypodium leucotomos extract supplement in a randomized clinical trial.

P. Ruiz, O. Perez, S. Amini, 2010, Journal of the American Academy of Dermatology.

Topical treatment of common superficial tinea infections.

B. Berman, A. Weinstein, 2002, American family physician.

Fatal pancreatitis presenting with subcutaneous fat necrosis. Evidence that lipase and amylase alone do not induce lipocyte necrosis.

B. Berman, C. Conteas, Bonnie Smith, 1987, Journal of the American Academy of Dermatology.

Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, double-blind, multicenter trials.

B. Berman, J. Leyden, M. Stiller, 1992, Journal of the American Academy of Dermatology.

Cutaneous signs and syndromes associated with internal malignancies.

B. Berman, C. Ramirez, 2005, Skinmed.

Ecthyma gangrenosum caused by Escherichia coli bacteremia: a case report and review of the literature.

Jitendrakumar K Patel, O. Perez, B. Berman, 2009, Cutis.

Prevention and Management of Hypertrophic Scars and Keloids After Burns in Children

S. Amini, B. Berman, R. Huo, 2008, The Journal of craniofacial surgery.

Treatment of Pigmented Hypertrophic Scars with the 585 nm Pulsed Dye Laser and the 532 nm Frequency‐Doubled Nd:YAG Laser in the Q‐Switched and Variable Pulse Modes: A Comparative Study

L. Bowes, B. Berman, K. Nouri, 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Updated International Clinical Recommendations on Scar Management: Part 1—Evaluating the Evidence

M. Gold, F. Nahai, G. Gauglitz, 2014, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis.

J. Koo, J. Fowler, B. Berman, 2006, Cutis.

Percutaneous dermal drug delivery for local pain control

B. Berman, Sujatha Tadicherla, 2006, Therapeutics and clinical risk management.

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles.

N. Swanson, D. Rigel, B. Berman, 2010, Journal of the American Academy of Dermatology.

Tolerability of Topical Treatments for Atopic Dermatitis

S. Feldman, Z. Draelos, B. Berman, 2019, Dermatology and Therapy.

Bioregulatory systems medicine: an innovative approach to integrating the science of molecular networks, inflammation, and systems biology with the patient's autoregulatory capacity?

Konstantin Cesnulevicius, David Lescheid, Alyssa W. Goldman, 2015, Front. Physiol..

Cutaneous disseminated histoplasmosis in AIDS patients in south Florida

R. Kirsner, B. Berman, H. Sasken, 1997, International journal of dermatology.

Efficacy of a 1-week, once-daily regimen of terbinafine 1% cream in the treatment of tinea cruris and tinea corporis.

B. Berman, L. Millikan, N. Zaias, 1993, Journal of the American Academy of Dermatology.

Treatment of Striae Rubra and Striae Alba With the 585‐nm Pulsed‐Dye Laser

B. Berman, Z. Gunja-Smith, F. Flores, 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Treatment of perifolliculitis capitis abscedens et suffodiens with the carbon dioxide laser.

B. Berman, L. Glass, D. Laub, 1989, The Journal of dermatologic surgery and oncology.

Modulation of expression of epidermal Langerhans cell properties following in situ exposure to glucocorticosteroids.

B. Berman, D. France, G. Martinelli, 1983, The Journal of investigative dermatology.

Correlation of skin disorders with CD4 lymphocyte counts in patients with HIV/AIDS.

B. Berman, E. Sukenik, S. Frankel, 1997, Journal of the American Academy of Dermatology.

New-onset Majocchi's granuloma in two kidney transplant recipients under tacrolimus treatment.

G. Elgart, B. Berman, A. Burdick, 1998, Journal of the American Academy of Dermatology.

HIV and AIDS in inpatient dermatology. Approach to the consultation.

B. Berman, M. Finkelstein, Michelle Finkelstein, 2000, Dermatologic clinics.

Treatment of Herpes simplex virus infections with topical antiviral agents.

B. Berman, R. Hamuy, 1998, European journal of dermatology : EJD.

Dermatologic uses of interferons.

B. Berman, M. Sequeira, 1995, Dermatologic clinics.

Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses

B. Berman, C. Caperton, 2011, Clinical, cosmetic and investigational dermatology.

Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapy.

S. Tyring, B. Berman, D. Whiting, 1992, Archives of dermatology.

Skin metastases from small-cell carcinoma of the lung.

P. G. Prioleau, J. Fox, B. Berman, 1983, The Journal of dermatologic surgery and oncology.

Adjunct Therapies to Surgical Management of Keloids

B. Berman, H. Bieley, 1996, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Herpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options

S. Konda, S. Amini, B. Berman, 2010, International journal of dermatology.

New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel

B. Berman, Brian Berman, 2012, Clinical, cosmetic and investigational dermatology.

Expert Consensus on Cosmetic Outcomes After Treatment of Actinic Keratosis.

D. Goldberg, B. Berman, R. Ceilley, 2017, Journal of drugs in dermatology : JDD.

Assessing keloid recurrence following surgical excision and radiation

M. Gold, B. Berman, M. Nestor, 2020, Burns & trauma.

A Review of the Biologic Effects, Clinical Efficacy, and Safety of Silicone Elastomer Sheeting for Hypertrophic and Keloid Scar Treatment and Management

S. Konda, O. Perez, B. Berman, 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections.

B. Berman, F. Flores, 1997, Journal of the American Academy of Dermatology.

Basal cell carcinoma presenting as a chronic finger ulcer.

J. West, B. Berman, 1990, Journal of the American Academy of Dermatology.

Suppression of human interferon production by inhibitors of glycosylation.

J. Vilček, E. Falcoff, E. A. Havell, 1975, Virology.

Current Understanding of Seborrheic Keratosis: Prevalence, Etiology, Clinical Presentation, Diagnosis, and Management.

Susan C. Taylor, B. Berman, J. Weiss, 2015, Journal of drugs in dermatology : JDD.

Establishment of a cell line retaining Langerhans cell characteristics.

B. Berman, D. France, 1980, The Journal of investigative dermatology.

The Human Interferon System

B. Berman, H. M. Frankfort, Howard M. Frankfort, 1982, International journal of dermatology.

Immunological strategies to fight skin cancer.

O. Perez, B. Berman, D. Zell, 2006, Skin therapy letter.

The treatment of hypertrophic scars and keloids.

B. Berman, F. Flores, 1999, European journal of dermatology : EJD.

Self‐Warming Lidocaine/Tetracaine Patch Effectively and Safely Induces Local Anesthesia during Minor Dermatologic Procedures

B. Berman, R. Pariser, D. Pariser, 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Evaluating the tolerability and efficacy of etanercept compared to triamcinolone acetonide for the intralesional treatment of keloids.

Jitendrakumar K Patel, O. Perez, S. Amini, 2008, Journal of drugs in dermatology : JDD.

Novel dermatologic uses of the immune response modifier imiquimod 5% cream.

B. Berman, V. Poochareon, A. Villa, 2002, Skin therapy letter.

Localized Indurated Brown Plaques on Arms and Right Buttock

B. Berman, B. Bellman, 1996 .

Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis

B. Berman, 2011 .

Histiocytosis X: treatment with topical nitrogen mustard.

B. Berman, J. Shupack, B. Berman, 1980, Journal of the American Academy of Dermatology.

Concurrent cutaneous and hepatic hemangiomata in infancy: report of a case and a review of the literature.

B. Berman, H. Lim, 1978, The Journal of dermatologic surgery and oncology.

Modulation of epidermal langerhans cell properties following in vitro and in situ exposure to gluco cortico steroids

B. Berman, 1981 .

Complement receptors on guinea pig epidermal Langerhans cells.

I. Gigli, B. Berman, 1980, Journal of immunology.

Histochemical analysis of Langerhans' cells.

B. Berman, 1979 .

A novel hydrogel scaffold for the prevention or reduction of the recurrence of keloid scars postsurgical excision.

B. Berman, E. Smith, Srikanth Garikaparthi, 2013, Journal of the American Academy of Dermatology.

Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro.

B. Berman, M. Duncan, 1989, Journal of the American Academy of Dermatology.

Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin

B. Berman, M. Duncan, B. BERMAN, 1990, The British journal of dermatology.

Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.

B. Berman, M. Nestor, N. Swenson, 2014, Journal of drugs in dermatology : JDD.

What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents.

S. Amini, B. Berman, D. Cohen, 2012, Cutis.

What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.

S. Amini, B. Berman, D. Cohen, 2012, Cutis.

Cytokines and Chemokines

O. Perez, B. Berman, 2008 .

The role of imiquimod 3.75% cream in the treatment of external genital warts.

B. Berman, J. Wolf, 2012, Skin therapy letter.

Quantitation of cutaneous Langerhans cells of sarcoidosis patients.

J. Fox, M. Reed, A. Teirstein, 1983, The Journal of investigative dermatology.

Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream.

B. Berman, Minerva Gómez, O. Welsh, 2004, Journal of the American Academy of Dermatology.

Mononuclear cells isolated from fibrotic skin lesions in avian scleroderma constitutively produce fibroblast-activating cytokines and immunoglobulin M.

M. Gershwin, J. A. Van de Water, B. Berman, 1995, International archives of allergy and immunology.

Successful management of viral infections and other dermatoses with imiquimod 5% cream.

U. Hengge, B. Berman, S. Barton, 2003, Acta dermato-venereologica. Supplementum.

Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma.

U. Nseyo, B. Berman, M. Duncan, 1991, Scandinavian journal of urology and nephrology.

Phenytoin-associated hypersensitivity syndrome with features of DRESS and TEN/SJS.

Jitendrakumar K Patel, O. Perez, B. Berman, 2010, Cutis.

Genital herpes infection: beyond a clinical diagnosis.

B. Berman, Adriana M. Villa, 2003, Skinmed.

The Expression of Toll-like Receptors in Dermatological Diseases and the Therapeutic Effect of Current and Newer Topical Toll-like Receptor Modulators.

S. Amini, B. Berman, W. Valins, 2010, The Journal of clinical and aesthetic dermatology.

Teledermatology and underserved populations.

B. Berman, A. Burdick, C M Phillips, 1997, Archives of dermatology.

Dermatology residency program characteristics that correlate with graduates selecting an academic dermatology career.

S. Tyring, B. Berman, Jashin J. Wu, 2006, Archives of dermatology.

A Retrospective Registry Study Evaluating the Long-Term Efficacy and Safety of Superficial Radiation Therapy Following Excision of Keloid Scars.

M. Gold, B. Berman, E. Weiss, 2020, The Journal of clinical and aesthetic dermatology.

An overview of superficial radiation of surgical keloidectomy sites to reduce keloid recurrences

B. Berman, 2020 .

Objective Assessment of the Precision, Accuracy, and Reliability of a Measurement Method for Keloid Scar Volume (PARKS Study)

V. Young, B. Berman, J. M. McAndrews, 2015, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Do postsurgical interventions optimize ultimate scar cosmesis.

S. Konda, S. Amini, B. Berman, 2009, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

Advances in the treatment of keloids.

B. Berman, C. Caperton, M. Viera, 2011, Journal of drugs in dermatology : JDD.

Low Rate of Keloid Recurrences Following Treatment of Keloidectomy Sites with a Biologically Effective Dose 30 of Superficial Radiation

J. Fox, B. Berman, M. Nestor, 2017, SKIN The Journal of Cutaneous Medicine.

Double‐Blind, Randomized, Placebo‐Controlled, Prospective Study Evaluating the Tolerability and Effectiveness of Imiquimod Applied to Postsurgical Excisions on Scar Cosmesis

B. Berman, K. Nouri, V. Poochareon, 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Update on Keloid Management: Clinical and Basic Science Advances.

A. Vivas, B. Berman, M. Viera, 2012, Advances in wound care.

Efficacy of aminolevulinic acid 20% solution combined with photodynamic therapy in the treatment of actinic keratoses on the upper extremities: A post hoc analysis of a phase 3, randomized, vehicle-controlled trial.

D. Piacquadio, D. Siegel, B. Berman, 2020, Photodiagnosis and photodynamic therapy.

A controlled cohort study examining the onset of hypertension in black patients with keloids.

B. Berman, Heather C Woolery-Lloyd, 2002, European journal of dermatology : EJD.

Biological Agents for Controlling Excessive Scarring

B. Berman, 2010, American journal of clinical dermatology.

Scientific rationale: combining imiquimod and surgical treatments for basal cell carcinomas.

B. Berman, 2008, Journal of drugs in dermatology : JDD.

Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report.

U. Nseyo, S. Lundahl, B. Berman, 1990, Urology.

A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia

M. Lacouture, J. Jimenez, E. Granger, 2020, Breast Cancer Research and Treatment.

A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9

B. Berman, 2011 .

Double-blind, Placebo-controlled Study Assessing the Effect of Chocolate Consumption in Subjects with a History of Acne Vulgaris.

B. Berman, J. Keri, C. Caperton, 2014, The Journal of clinical and aesthetic dermatology.

The aging skin.

B. Berman, E. C. Gomez, 1985, Clinics in Geriatric Medicine.

Exacerbation of facial acne vulgaris after consuming pure chocolate.

S. Amini, B. Berman, C. Caperton, 2011, Journal of the American Academy of Dermatology.

Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study

B. Berman, 2011 .

Kaposi's sarcoma, chronic ulcerative herpes simplex, and acquired immunodeficiency.

B. Berman, W. Dotz, 1983, Archives of dermatology.

Eruptive seborrheic keratoses in a young woman with acromegaly.

B. Berman, V. Morhenn, S. Kilmer, 1990, Journal of the American Academy of Dermatology.

Fas-ligand staining in non-drug- and drug-induced maculopapular rashes

B. Berman, S. Amini, 2012 .

Rating the 4-Star UVA Protection Rating System

S. Amini, B. Berman, M. Viera, 2010 .

Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream.

N. Swanson, B. Berman, C. Hanke, 2011, Journal of drugs in dermatology : JDD.

Efficacy Endpoints in Clinical Trials in Actinic Keratosis

T. Skov, E. Stockfleth, B. Berman, 2018, Dermatology and Therapy.

Three-Day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: Cosmetic Outcomes and Patient Satisfaction from a Phase II Trial.

S. Tyring, D. Siegel, B. Berman, 2017, The Journal of clinical and aesthetic dermatology.

Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results.

N. Swanson, S. Tyring, G. Goldenberg, 2014, Journal of drugs in dermatology : JDD.

Field Treatment of Actinic Keratosis With Ingenol Mebutate.

E. Stockfleth, B. Berman, 2016, Journal of Drugs in Dermatology.

Actinic keratoses: sequelae and treatments. Recommendations from a consensus panel.

E. J. Mayeaux, L. Kuritzky, S. Tyring, 2006, The Journal of family practice.

Imiquimod 2.5% and 3.75% Cream for the Treatment of Photodamage: A Meta-analysis of Efficacy and Tolerability in 969 Randomized Patients.

N. Swanson, B. Berman, T. Rosen, 2018, The Journal of clinical and aesthetic dermatology.

Safety and Efficacy of Escalating Doses of Ingenol Mebutate for Field Treatment of Actinic Keratosis on the Full Face, Full Balding Scalp, or Chest.

N. Swanson, T. Skov, D. Siegel, 2017, Journal of drugs in dermatology : JDD.

Favorable Safety Profile of Tirbanibulin Ointment 1% for Actinic Keratosis: Pooled Results from Two Phase III Studies

M. Lebwohl, A. Grada, B. Berman, 2020 .

Topical antiviral agents for herpes simplex virus infections.

B. Berman, R. Hamuy, 1998, Drugs of today.

An Investigator Blinded Randomized Study Evaluating HOCl in the Treatment of Atopic Dermatitis-Associated Pruritus

B. Berman, M. Nestor, 2017 .

Pathways to managing atopic dermatitis: consensus from the experts.

William Abramovits, M. Lebwohl, E. Guttman, 2013, The Journal of clinical and aesthetic dermatology.

Addition of short-contact anthralin therapy to an ultraviolet B phototherapy regimen: assessment of efficacy.

M. Lebwohl, B. Berman, D. France, 1985, Journal of the American Academy of Dermatology.

Presentation of reticulate acropigmentation of kitamura and dowling-degos disease overlap.

B. Berman, J. Tang, M. Shiman, 2012, The Journal of clinical and aesthetic dermatology.

The Histamine H4 Receptor Mediates Inflammation and Pruritus in Th2-Dependent Dermal Inflammation

B. Berman, 2011 .

Update on rosacea and anti-inflammatory-dose doxycycline.

O. Perez, B. Berman, D. Zell, 2007, Drugs of today.

Membrane-bound intracellular interferon in rabbit kidney cell cultures.

J. Vilček, B. Berman, M. Nu, 1972, Virology.

Is eosinophilia helpful in diagnosing drug eruptions?

B. Berman, Adriana M. Villa, 2002, Skinmed.

Understanding the Role of Photolyases: Photoprotection and Beyond.

B. Berman, R. Ceilley, L. Kircik, 2017, Journal of Drugs in Dermatology.

Profile of Tirbanibulin for the Treatment of Actinic Keratosis.

B. Berman, A. Grada, Daniela K. Berman, 2022, The Journal of clinical and aesthetic dermatology.

Purpura fulminans in a patient with malaria.

A. Falabella, B. Berman, J. Keri, 2000, EJD. European journal of dermatology.

Targeted treatment of pruritus: a look into the future

B. Berman, S. Amini, 2012 .

Subantimicrobial dose doxycycline: a unique treatment for rosacea.

B. Berman, D. Zell, 2005, Cutis.

A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA).

M. Lacouture, J. Jimenez, B. Berman, 2017 .

Clinical, Cosmetic and Investigational Dermatology Dovepress Safety, Efficacy, and Patient Acceptability of Imiquimod for Topical Treatment of Actinic Keratoses

B. Berman, C. Caperton, 2022 .

Toxic epidermal necrolysis in the setting of systemic lupus erythematosus

C. Milikowski, S. Konda, G. Elgart, 2011, International journal of dermatology.

Clinical, Cosmetic and Investigational Dermatology New Developments in the Treatment of Actinic Keratosis: Focus on Ingenol Mebutate Gel

B. Berman, 2022 .

Herpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options

S. Konda, S. Amini, B. Berman, 2010, International journal of dermatology.

Safety and Efficacy of Aminolevulinic Acid 10% Topical Gel versus Aminolevulinic Acid 20% Topical Solution Followed by Blue-light Photodynamic Therapy for the Treatment of Actinic Keratosis on the Face and Scalp: A Randomized, Double-blind Study.

B. Berman, M. Nestor, Jigesh Patel, 2019, The Journal of clinical and aesthetic dermatology.

Gene expression profiling reveals alteration of caspase 6 and 14 transcripts in normal skin of keloid-prone patients

G. Elgart, B. Berman, V. Vincek, 2009, Archives of Dermatological Research.